Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-12-14
pubmed:abstractText
1. The pharmacological properties of RS 23597-190 (3-(piperdine-1-yl)-propyl-4-amino-5-chloro-2-methoxy benzoate hydrochloride) have been studied in vitro and in vivo. 2. RS 23597-190 competitively antagonized 5-HT4 receptor-mediated relaxations of rat, carbachol precontracted oesophageal muscularis mucosae, (pA2 = 7.8 +/- 0.1; Schild slope = 1.2 +/- 0.2). Affinity estimates (-log KB) at 5-HT4 receptors using either renzapride or SC-53116 as agonists yielded a -log KB value of 8.0 +/- 0.01. In contrast, RS 23597-190 failed to antagonize contractile responses to 5-HT of guinea-pig ileal 5-HT3 receptors, even at concentrations up to 10 microM. 3. Increases in short-circuit current, induced by 5-HT, were studied in guinea-pig ileal mucosal sheets. Concentration-response curves to 5-HT were biphasic, with the high potency phase to 5-HT inhibited by RS 23597-190 and mimicked by 5-methoxytryptamine. The -log KB value for RS 23597-190 at the high potency phase was 7.3 confirming that 5-HT4 receptors mediated the high potency phase. 4. In rat isolated vagus nerve, 5-HT elicited a slow, maintained depolarization at low concentrations and a rapid, transient depolarization at higher concentrations. The high potency, slow depolarizing phase to 5-HT was abolished selectively in the presence of 1 microM RS 23597-190 and the low potency phase was abolished selectively in the presence of 1 microM ondansetron. These data confirm that 5-HT4 and 5-HT3 receptors mediated slow and fast depolarization responses, respectively. 5. At 5-HT3 binding sites in membranes from NG 108-15 cells, labelled by [3H]-quipazine, RS 23597-190 exhibited an apparent affinity (- log Ki) of 5.7 +/- 0.1. At 5-HT3 receptors in membranes from rat cerebral cortex, labelled by [3H]-RS 42358-197, the apparent affinity (- log Ki) of RS 23597-190 was also 5.7 +/- 0.1. In both studies, Hill coefficients were not significantly different from unity. At 5-HT1A, 5-HT2,muscarinic M1, M2, M3, M4 and dopamine D1 and D2 receptors, RS 23597-190 exhibited low apparent affinities, with all - log Ki values less than 5.5.6. Intravenous infusion of RS 23597-190 in the conscious, restrained rat antagonized the von Bezold Jarisch reflex induced by 2-methyl 5-HT, with an ID50 of 300 microg kg-1 min-1, i.v. In the anaesthetized,bilaterally vagotomized micropig, RS 23597-190 (6 mg kg-1, i.v.) antagonized 5-HT-induced tachycardia with a half-life of 77 (63-99) min. Transient arrhythmic effects were noted after administration of the compound.7. In conclusion, RS 23597-190 acts as a high affinity, selective competitive antagonist at 5-HT4 receptors. Thus, the compound appears to be a useful tool for 5-HT4 receptor identification in vitro. In vivo, the compound is rapidly metabolized in pigs such that 5-HT4 blockade is not maintained. However,in the rat, when given by infusion, RS 23597-190 antagonizes 5-HT3 mediated responses, at doses consistent with a low affinity 5-HT3 receptor. These data suggest that, under appropriate experimental conditions, RS 23597-190 may also be used in vivo to characterize further 5-HT4 receptor function.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1320204, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-13651579, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1384896, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1393286, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1438521, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1470221, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1551411, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1573641, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1589907, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1620231, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1620241, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1633936, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1663456, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1718042, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1830236, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-1881455, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-2076474, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-2207493, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-2402303, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-2458457, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-2472554, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-3350057, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-3683864, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-3814920, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-3839291, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-5566763, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-6254391, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-8436978, http://linkedlifedata.com/resource/pubmed/commentcorrection/8220871-8448587
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
119-26
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:8220871-4-Aminobenzoic Acid, pubmed-meshheading:8220871-Aminobenzoic Acids, pubmed-meshheading:8220871-Animals, pubmed-meshheading:8220871-Blood Pressure, pubmed-meshheading:8220871-Electrophysiology, pubmed-meshheading:8220871-Female, pubmed-meshheading:8220871-Guinea Pigs, pubmed-meshheading:8220871-Heart Rate, pubmed-meshheading:8220871-Intestinal Mucosa, pubmed-meshheading:8220871-Male, pubmed-meshheading:8220871-Metoclopramide, pubmed-meshheading:8220871-Muscle, Smooth, pubmed-meshheading:8220871-Muscle Contraction, pubmed-meshheading:8220871-Muscle Relaxation, pubmed-meshheading:8220871-Piperidines, pubmed-meshheading:8220871-Radioligand Assay, pubmed-meshheading:8220871-Rats, pubmed-meshheading:8220871-Reflex, pubmed-meshheading:8220871-Serotonin, pubmed-meshheading:8220871-Serotonin Antagonists, pubmed-meshheading:8220871-Swine, pubmed-meshheading:8220871-Swine, Miniature, pubmed-meshheading:8220871-Vagus Nerve
pubmed:year
1993
pubmed:articleTitle
RS 23597-190: a potent and selective 5-HT4 receptor antagonist.
pubmed:affiliation
Institute of Pharmacology, Syntex Discovery Research, Palo Alto, CA 94304.
pubmed:publicationType
Journal Article, In Vitro